Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance

This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates.

Detalles Bibliográficos
Autores principales: Cham, Stephanie, Landrum, Mary Beth, Keating, Nancy L., Armstrong, Joanne, Wright, Alexi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753497/
https://www.ncbi.nlm.nih.gov/pubmed/35015069
http://dx.doi.org/10.1001/jamanetworkopen.2021.42703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753497/
https://www.ncbi.nlm.nih.gov/pubmed/35015069
http://dx.doi.org/10.1001/jamanetworkopen.2021.42703

Ejemplares similares